RoslinCT is a clinical-stage cell and gene therapy company focused on advancing innovative therapies to treat serious diseases. The company specializes in the development of genetically modified cell therapies, particularly in the areas of oncology and rare diseases, leveraging cutting-edge technologies to create transformative treatment solutions.